Open Call for Research Proposals for BioCanRx
BioCanRx, Canada’s Immunotherapy Network, is launching its first Open Call for Research Proposals, made possible by funding from the Strategic Science Fund. By funding the selected proposals, BioCanRx will increase support for multi-disciplinary cancer immunotherapy and biotherapeutic approaches. More information is available here: https://biocanrx.com/research/research-program/open-call-2024
Winner of the 2023 PIP Grant Competition
Participants and supporters of the 2023 PIP are pleased to announce that Dr. Nawal Amhis is the winner of the 2023 PIP grant competition, a one-year grant of $15,000, for her project, “Remodeling of the pancreatic tumour microenvironment with oncolytic virotherapy.” Dr. Amhis is a medical res... Read More »
Participants and supporters of the 2023 PIP are pleased to announce that Dr. Nawal Amhis is the winner of the 2023 PIP grant competition, a one-year grant of $15,000, for her project, “Remodeling of the pancreatic tumour microenvironment with oncolytic virotherapy.” Dr. Amhis is a medical res... Read More »
Investment in Cancer Research in 2022
Today, the CCRA released its latest report on the investment in cancer research from 2005 to 2022, with a focus on the period 2020-2022 to examine the potential impact of COVID-19. There was $526M invested in cancer research in 2022. The overall cancer research inve... Read More »
Today, the CCRA released its latest report on the investment in cancer research from 2005 to 2022, with a focus on the period 2020-2022 to examine the potential impact of COVID-19. There was $526M invested in cancer research in 2022. The overall cancer research inve... Read More »